Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BERGEN-BRUNSWIG WILL OPEN FULLY AUTOMATED 213,000 SQ. FT. CENTER

Executive Summary

BERGEN-BRUNSWIG WILL OPEN FULLY AUTOMATED 213,000 SQ. FT. CENTER that "consolidates the operations of three smaller and less efficient distribution centers," Bergen Exec VP Dwight Steffensen announced at the Sept. 11-13 meeting of the International Federation of Pharmaceutical Wholesalers. The completely automated regional distribution facility will open next month in Corona, Calif. "We believe it will be the most technologically advanced facility in the industry," Steffensen stated. "An automated picking system will store and dispense more than 2,500 of the fastest moving prescription and OTC products," accounting for nearly 50% of the products that will be handled by the facility, he said. "The Corona facility represents an investment of $25 mil.," Steffensen noted. He pointed out that $5 mil. was invested solely in the plant's automated system. However, Bergen expects the investment to reap savings in the long term, he indicated. Both an automated regional center in Valencia, California and the Corona facility "are designed to handle an annual sales volume in excess of $1 bil. at an expense level of less than 2%," he said. F. Dohmen President Erwin Dohmen also highlighted efforts by his company to automate distribution. Dohmen noted that his company is a privately owned, regional distribution company that purchases from 1,000 vendors and sells to 7,800 customers. The wholesaler serves a Midwest area measuring 500 miles from north to south, from Lake Superior to Chicago, and 200 miles wide, from Lake Michigan to the Mississippi River. Despite its relatively small size, the 132 year-old firm "is committed to a totally paperless system through business application of electronic data interchange," Dohmen said. The company "operates without manual intervention," he said, noting that "99% of our customer orders are received electronically" and "85% of our inventory, as measured in dollar volume, is ordered electronically from our manufacturers." Dohmen added that the firm has "tested electronic invoices with quite a few suppliers and [is] currently testing our internal programs" for digitalized invoice data and for updates of inventory internal records through electronic funds transfer.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS018054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel